Models of experimental pseudomonas keratitis: microbiological and clinical aspects

  • N.V. Malachkova
  • N.V. Kryvetska
  • I.M. Vovk
  • I.M. Kovalenko
  • A.V. Kryzhanovskaya
Keywords: Pseudomonas aeruginosa, experimental keratitis.


Annotation. Over the last ten years, there has been an increase in the incidence of bacterial keratitis caused by Pseudomonas aeruginosa, associated with contact lenses use. Certain features of the course of such keratitis, the mechanisms of corneal damage, the factors that affect the severity and depth of tissue destruction remain unclear. Therefore, the aim of our work was to model experimental pseudomonal keratitis in rabbits using different methods of infection and to investigate the microbiological and clinical aspects of keratitis depending on the method of infection. As a result of the study, we were able to reproduce superficial and deep keratitis with different methods of infection. Our proposed method cornea infection with bacterial films on a contact lens allowed to reproduce severe keratitis with a longer release of the pathogen from the surface of the affected cornea. It was also found that the results of microbiological examination of the material from the affected eye do not correlate with the course of severe keratitis: negative results of microbiological examination did not demonstrate the elimination of the pathogen from eye tissues, which deepens into corneal tissues, that was proved with microbiological examination of the cornea autopsy samples. These models of experimental keratitis can be used to study the pathomorphology, and pathophysiology of the keratitis caused by Pseudomonas aeruginosa, as well as to conduct experimental research of new antimicrobials and improve current guidelines for treatment of this pathology.


1. Efimova, Yu. V., & Vitovskaya, O. P. (2015). Effektivnost primeneniya ftorhinolonov v lechenii keratitov [Efficacy of quinolones for keratitis treatment] Arhiv oftalmologii Ukrainy – Archive of Ophthalmology Ukraine, 3 (2), 65–69. Vziato z

2. Malachkova, N. V., Kryvetska, N. V., Vovk, I. M., & Kryvetskiy, V. F. (2020). Patent Ukraine 141155. Kyiv: State Patent Office of Ukraine.

3. Malachkova, N. V., Kryvetska, N. V., Vovk, I. M., & Kryvetskiy, V. F. (2020) Patent Ukraine 141156. Kyiv: State Patent Office of Ukraine.

4. Petrunya, A. M., & Kutajni, M. A. (2013). Izuchenie klinicheskih priznakov vospalitelnogo processa v rogovoj obolochke pri odnovremennom modelirovanii keratita i konyunktivita v eksperimente [Study of clinical inflammatory signs in a cornea at simultaneous experimental keratitis and conjunctivitis]. Oftalmologicheskij zhurnal - Journal of Ophthalmology, 2, 83–88. Vzyato s

5. Shelkova, N. H., & Prokopets, V. P. (2009). Metod kilkisnoho doslidzhennia vmistu bakterii u klinichnykh materialakh, shcho vidibrani za dopomohoiu vatnoho tampon [Quantitative assay of bacterial number in clinical samples collected with cotton swabs]. Zbirnyk naukovykh prats spivrobitnykiv NMAPO – Scientific works collection of NMAPE, 17, (2), 698–702. Kyiv.

6. Begum Bulam Kilic, Dilek Dursun Altiors, Muge Demirbilek, & Ersin Ogus. (2017). Comparison between corneal cross-linking, topical antibiotic and combined therapy in experimental bacterial keratitis model. Saudi Jornal of Ophthalmology, 32 (2), 97–104. DOI: 10.1016/j.sjopt.2017.10.003.

7. Green, M., Apel, A., & Stapleton, F. (2008). Risk factors and causative organisms in microbial keratitis. Cornea, 27 (1), 22–27. doi: 10.1097/ICO.0b013e318156caf2.

8. Jin, H., Parker, W. T., Law, N. W., Clarke, C. L., Gissman, J. D., Pflugfelder, … Al-Mohtaseb, Z. N. (2017). Evolving risk factors and antibiotic sensitivity patterns for microbial keratitis at a large county hospital. The British Jornal of Ophthalmology, 101 (11), 1483–1487. DOI: 10.1136/bjophthalmol-2016-310026.

9. Marquart, M. E. (2011). Animal Models of Bacterial Keratitis. Journal of Biomedicine and Biotechnology, 2011, 680642. doi: 10.1155/2011/680642.

10. McClellan, S., Jiang, X., Barrett, R., & Hazlet, L. D. (2015). High mobility Group Box 1: A Novel Target for Treatment of Pseudomonas aeruginosa keratitis. Journal of Immunology, 194, 1776–1787. doi: 0.4049/jimmunol.1401684.

11. Truong, D. T., Bui, M.-Th., Memon, P., & Dwight Cavanagh, H. (2015). Microbial Keratitis at an Urban Public Hospital: A 10-Year Update. Jornal of Clinical and Expiremental Ophthalmology, 6 (6), 498. doi: 10.4172/2155-9570.1000498.

12. Zimmerman, A. B., Nixon, A. D. & Rueff, E. M. (2016). Contact lens associated microbial keratitis: practical considerations for the optometrist. Clinical Optometry, 8, 1–12. doi: 10.2147/OPTO.S66424.
How to Cite
Malachkova, N., Kryvetska, N., Vovk, I., Kovalenko, I., & Kryzhanovskaya, A. (2020). Models of experimental pseudomonas keratitis: microbiological and clinical aspects. Reports of Vinnytsia National Medical University, 24(1), 129-133.